These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10447960)

  • 1. Development of predictive retention-activity relationship models of tricyclic antidepressants by micellar liquid chromatography.
    Quiñones-Torrelo C; Sagrado S; Villanueva-Camañas RM; Medina-Hernández MJ
    J Med Chem; 1999 Aug; 42(16):3154-62. PubMed ID: 10447960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retention-activity relationship studies of benzodiazepines by micellar liquid chromatography.
    Molero-Monfort M; Sagrado S; Villanueva-Camañas RM; Medina-Hernández MJ
    Biomed Chromatogr; 1999 Oct; 13(6):394-400. PubMed ID: 10477896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of predictive quantitative retention-activity relationship models of HMG-CoA reductase inhibitors by biopartitioning micellar chromatography.
    Wang SR; Chen Y; Wu LP; Miao WJ; Xiong MJ; Chen C; Zhong ZR; Ye LM
    J Pharm Biomed Anal; 2008 Jan; 46(2):243-9. PubMed ID: 18024049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Designing a new generation of antidepressant drugs.
    Pinder RM
    Acta Psychiatr Scand Suppl; 1997; 391():7-13. PubMed ID: 9265946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retention pharmacokinetic and pharmacodynamic parameter relationships of antihistamine drugs using biopartitioning micellar chromatography.
    Quiñones-Torrelo C; Sagrado S; Villanueva-Camañas RM; Medina-Hernández MJ
    J Chromatogr B Biomed Sci Appl; 2001 Sep; 761(1):13-26. PubMed ID: 11585127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of predictive retention-activity relationship models of antipsychotic drugs by micellar liquid chromatography.
    Martín-Biosca Y; Molero-Monfort M; Sagrado S; Villanueva-Camañas RM; Medina-Hernández MJ
    Biomed Chromatogr; 1999 Nov; 13(7):478-92. PubMed ID: 10534760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.
    Lucas MC; Weikert RJ; Carter DS; Cai HY; Greenhouse R; Iyer PS; Lin CJ; Lee EK; Madera AM; Moore A; Ozboya K; Schoenfeld RC; Steiner S; Zhai Y; Lynch SM
    Bioorg Med Chem Lett; 2010 Sep; 20(18):5559-66. PubMed ID: 20691589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of predictive retention-activity relationship models of non-steroidal anti-inflammatory drugs by micellar liquid chromatography: comparison with immobilized artificial membrane columns.
    Escuder-Gilabert L; Sagrado S; Villanueva-Camañas RM; Medina-Hernández MJ
    J Chromatogr B Biomed Sci Appl; 2000 Mar; 740(1):59-70. PubMed ID: 10798294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the physicochemical and biological properties of mirtazapine and mianserin.
    Kelder J; Funke C; De Boer T; Delbressine L; Leysen D; Nickolson V
    J Pharm Pharmacol; 1997 Apr; 49(4):403-11. PubMed ID: 9232538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of serotonin reuptake inhibitors with tricyclic antidepressants.
    Popli AP; Baldessarini RJ; Cole JO
    Arch Gen Psychiatry; 1994 Aug; 51(8):666-7. PubMed ID: 8042918
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of predictive retention-activity models of butyrophenones by biopartitioning micellar chromatography.
    Martín-Biosca Y; Molero-Monfort M; Sagrado S; Villanueva-Camañas RM; Medina-Hernández MJ
    Biomed Chromatogr; 2001 Aug; 15(5):334-41. PubMed ID: 11507715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tricyclic isoxazolines: identification of R226161 as a potential new antidepressant that combines potent serotonin reuptake inhibition and alpha2-adrenoceptor antagonism.
    Andrés JI; Alcázar J; Alonso JM; Alvarez RM; Bakker MH; Biesmans I; Cid JM; De Lucas AI; Drinkenburg W; Fernández J; Font LM; Iturrino L; Langlois X; Lenaerts I; Martínez S; Megens AA; Pastor J; Pullan S; Steckler T
    Bioorg Med Chem; 2007 Jun; 15(11):3649-60. PubMed ID: 17407815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tricyclic Antidepressants and Monoamine Oxidase Inhibitors: Are They Too Old for a New Look?
    Chockalingam R; Gott BM; Conway CR
    Handb Exp Pharmacol; 2019; 250():37-48. PubMed ID: 30105472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accumulation of cyclic adenosine monophosphate in incubated slices of brain tissue. 1. Structure-activity relationships of agonists and antagonists of biogenic amines and of tricyclic tranquilizers and antidepressants.
    Huang M; Daly JW
    J Med Chem; 1972 May; 15(5):458-62. PubMed ID: 4402483
    [No Abstract]   [Full Text] [Related]  

  • 15. Differential modulation of efficiency in a food-rewarded "differential reinforcement of low-rate" 72-s schedule in rats by norepinephrine and serotonin reuptake inhibitors.
    Dekeyne A; Gobert A; Auclair A; Girardon S; Millan MJ
    Psychopharmacology (Berl); 2002 Jul; 162(2):156-67. PubMed ID: 12110993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions between sertraline and tricyclic antidepressants.
    Lydiard RB; Anton RF; Cunningham T
    Am J Psychiatry; 1993 Jul; 150(7):1125-6. PubMed ID: 8317590
    [No Abstract]   [Full Text] [Related]  

  • 17. Fluvoxamine and tricyclic antidepressants (TCAs): how do the TCAs compare as "new" drugs with established fluvoxamine?
    Ashford JJ
    Int Clin Psychopharmacol; 1995 Jan; 9 Suppl 4():27-31. PubMed ID: 7622820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of the newer antidepressants. An overview of the pharmacological and pharmacokinetic implications.
    Caccia S
    Clin Pharmacokinet; 1998 Apr; 34(4):281-302. PubMed ID: 9571301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of biopartitioning micellar chromatography and immobilized artificial membrane column for in silico and in vitro determination of blood-brain barrier penetration of phenols.
    Stępnik KE; Malinowska I
    J Chromatogr A; 2013 Apr; 1286():127-36. PubMed ID: 23506703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacokinetics and drug interactions of antidepressive agents].
    Sawada Y; Ohtani H
    Nihon Rinsho; 2001 Aug; 59(8):1539-45. PubMed ID: 11519155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.